Trial Outcomes & Findings for Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin (NCT NCT02465164)
NCT ID: NCT02465164
Last Updated: 2023-05-22
Results Overview
Cook Only group Cook + Pitocin group N Mean (hrs) (SD) 16 27.9 (9.6) 10 23 14.6)
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
26 participants
Primary outcome timeframe
Up to 60 hours
Results posted on
2023-05-22
Participant Flow
Participant milestones
| Measure |
Cook Catheter
Control
Cook catheter
|
Cook Catheter Plus Low Dose Oxytocin
Test group
Cook catheter
Oxytocin
|
|---|---|---|
|
Overall Study
STARTED
|
16
|
10
|
|
Overall Study
COMPLETED
|
16
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin
Baseline characteristics by cohort
| Measure |
Cook Catheter
n=16 Participants
Control
Cook catheter
|
Cook Catheter Plus Low Dose Oxytocin
n=10 Participants
Test group
Cook catheter
Oxytocin
|
Total
n=26 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
16 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
22 years
STANDARD_DEVIATION 1.2 • n=5 Participants
|
24 years
STANDARD_DEVIATION 1.3 • n=7 Participants
|
23 years
STANDARD_DEVIATION 1.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
16 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 60 hoursCook Only group Cook + Pitocin group N Mean (hrs) (SD) 16 27.9 (9.6) 10 23 14.6)
Outcome measures
| Measure |
Cook Catheter
n=16 Participants
Control
Cook catheter
|
Cook Catheter Plus Low Dose Oxytocin
n=10 Participants
Test group
Cook catheter
Oxytocin
|
|---|---|---|
|
Time to Delivery (in Hours)
|
27 hours
Interval 12.0 to 54.0
|
23 hours
Interval 7.0 to 33.0
|
Adverse Events
Cook Catheter
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Cook Catheter Plus Low Dose Oxytocin
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Central Clinical Trials Office
Central Clinical Trials Office
Phone: 3139537454
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place